Abstract
This study evaluated the effects of Polycan, a β-glucan produced by Aureobasidium pullulans SM-2001, on calcium (Ca) bioavailability in an ovariectomy (OVX) model and a thyroparathyroidectomy (TPTX) model of osteoporosis in the SD rat. Polycan (62.5, 125, and 250 mg/kg body weight) was administered daily with an oral gavage for 4 weeks in both the OVX group (beginning 10 weeks following OVX surgery) and the TPTX group (beginning 4 days following TPTX surgery) while a commercial food product containing 1% milk-borne Ca was available ad libitum. After 4 weeks of Polycan administration, all animals were sacrificed and changes in bone mineral density (BMD) in the femur, tibia, and lumbar vertebrae (L6) were analyzed using dual-energy X-ray absorptiometry. Ca intake was calculated based on the amount of food intake during the 24 h period prior to sacrifice and the Ca balance, absorption, and retention ratios were calculated based on Ca intake, urinary and faecal Ca content, and Ca balance. Polycan treatment resulted in a marked increase in the BMD of the femur, tibia, and L6 relative to the OVX and TPTX controls with concomitant increases in Ca bioavailability and decreases in secreted Ca. These findings indicate that Polycan may enhance the absorption and bioavailability of Ca and improve Ca balance.
Similar content being viewed by others
References
Sakai, A. et al. Bone marrow cell development and trabecular bone dynamics after ovariectomy in ddy mice. Bone. 23, 443–451 (1998).
Yamaguchi, K. et al. Suppressive effect of norzoanthamine hydrochloride on experimental osteoporosis in ovariectomized mice. Biol. Pharm. Bull. 22, 920–924 (1999).
Melton, L. J. et al. How many women have osteoporosis? J. Bone. Miner. Res. 20, 886–892 (2005).
Kruger, M. C. et al. The effect of fructooligosaccharide with various degrees of polymerization on calcium bioavailability in growing rat. Exp. Biol. Med. 228, 683–688 (2003).
Heaney, R. P. et al. Peak bone mass. Osteoporosis Int. 11, 985–1009 (2002).
Louie, D. S. in Calcium and phosphorus in health and disease: Intestinal bioavailability and absorption of calcium (CRC press, Boca Raton, 1996).
Lifschitz, C. H., Grusak, M. A. & Butte, N. F. Carbohydrate digestion in humans from a beta-glucan-enriched barley is reduced. J. Nutr. 132, 2593–2596 (2002).
Lopez, H. W. et al. Fructooligosaccharides enhance mineral apparent absorption and counteract the deleterious effects of phytic acid on mineral homeostasis in rats. J. Nutr. Biochem. 11, 500–508 (2000).
Roberfroid, M. B. Concepts of functional foods: the case of inulin and oligofructose. J. Nutr. (Suppl.) 129, 1398–1401 (1999).
Hara, H., Haga, S., Aoyama, Y. & Kiriyama, S. Shortchain fatty acids suppress cholesterol synthesis in rat liver and intestine. J. Nutr. 129, 942–948 (1999).
Hara, H., Haga, S., Kasai, T. & Kiriyama, S. Fermentation products of sugar-beet fiber by cecal bacteria lower plasma cholesterol concentration in rats. J. Nutr. 128, 688–693 (1998).
Morohashi, T., Ohta, A. & Yamada, S. Dietary fructooligosaccharides prevent a reduction of cortical and trabecular bone following total gastrectomy in rats. Jpn. J. Pharmacol. 82, 54–58 (2000).
Scholz-Ahrens, K. E. et al. Effects of prebiotics on mineral metabolism. Am. J. Clin. Nutr. (Suppl.) 73, 459–464 (2001).
Seo, H. P. et al. Production of-1,3/1,6-glucan by Aureobasidium pullulans SM-2001. Korean J. Bitechnol. Bioeng. 17, 376–380 (2002).
Song, H. B. et al. Effect of exopolymers of Aureobasidium pullulans on improving osteoporosis induced in ovariectomized mice. J. Microbiol. Biotechnol. 16, 37–45 (2006).
Shin, H. D. et al. Antiosteoporotic effect of polycan, β-Glucan from Aureobasidium, in ovariectomized osteoporotic mice. Nutrition. 23, 853–860 (2007).
Czop, J. K. The role of beta-glucan receptors on blood and tissue leukocytes in phagocytosis and metabolic activation. Pathol. Immunopathol. Res. 5, 286–296 (1986).
Bell, S. et al. Effect of beta-glucan from oats and yeast on serum lipids. Crit. Rev. Food Sci. Nutr. 39, 189–202 (1999).
Luegmayr, E. et al. Osteoclast formation, survival and morphology are highly dependent on exogenous cholesterol/lipoproteins. Cell Death Differ. (Suppl.) 11, 108–118 (2004).
Choi, J.-S. et al. Antiosteoporotic effects of Polycan in combination with calcium lactate-gluconate in ovariectomized rats. Exp. Ther. Med. 8, 957–967 (2014).
Choi, J.-S. et al. Safety and efficacy of polycalcium for improving biomarkers of bone metabolism: a 4-week open-label clinical study. J. Med. Food. 16, 263–267 (2013).
Wronski, T. J., Yen, C. F. & Scott, K. S. Estrogen and diphosphonate treatment provide long-term protection against osteopenia in ovariectomized rats. J. Bone Miner. Res. 6, 387–394 (1991).
Frost, H. M. & Jee, W. S. On the rat model of human osteopenias and osteoporoses. Bone Miner. 18, 227–236 (1992).
US Food and Drug Administration in FDA Guidelines for preclinical and clinical evaluation of agents for the treatment or prevention of postmenopausal osteoporosis (Rockville, FDA, USA, 1994).
Wergedal, J., Stauffer, M., Baylink, D. & Rich, C. Inhibition of bone matrix formation, mineralization, and resorption in thyroparathyroidectomized rats. J. Clin. Invest. 52, 1052–1058 (1973).
Baylink, D., Stauffer, M., Wergedal, J. & Rich, C. Formation, mineralization, and resorption of bone in vitamin D-deficient rats. J. Clin. Invest. 49, 1122–1134 (1970).
Lorden, J. F. & Caudle, A. Behavioral and endocrinological effects of single injections of monosodium glutamate in the mouse. Neurobehav. Toxicol. Teratol. 8, 509–519 (1986).
Kang, S. A. et al. Effect of yeast beta-glucan on serum lipids and leptin levels in the diet-induced obese rats. Asia Pac. J. Clin. Nutr. 14, S114 (2005).
Garel, J. M., Gilbert, M. & Besnard, P. Fetal growth and 1,25-dihydroxyvitamin D3 injections into thyroparathyroidectomized pregnant rats. Reprod. Nutr. Dev. 21, 961–968 (1981).
Syed, Z. & Khan, A. Bone densitometry: applications and limitations. J. Obstet. Gynaecol. Can. 24, 476–484 (2002).
Diez, F. Guidelines for the diagnosis of osteoporosis by densitometric methods. J. Manipulative. Physiol. Ther. 25, 403–415 (2002).
Holzherr, M. L. et al. Calcium absorption in postmenopausal osteoporosis: benefit of HRT plus calcitriol, but not HRT alone, in both malabsorbers and normal absorbers. Osteoporos. Int. 11, 43–51 (2000).
Kalu, D. N. & Orhii, P. B. Calcium absorption and bone loss in ovariectomized rats fed varying levels of dietary calcium. Calcif. Tissue Int. 65, 73–77 (1999).
Chen, C., Noland, K. A. & Kalu, D. N. Modulation of intestinal vitamin D receptor by ovariectomy, estrogen and growth hormone. Mech. Ageing Dev. 99, 109–122 (1997).
Ten Bolscher, M. et al. Estrogen regulation of intestinal calcium absorption in the intact and ovariectomized adult rat. J. Bone. Miner. Res. 14, 1197–1202 (1999).
Barrett, E. J. & Barrett, P. in The parathyroid glands and vitamin D (eds Boron, W. F. & Boulpaep, E. L.) 1110–(Elsevier Saunders, Philadelphia, PA, USA, 2003).
Arden, N. K. et al. Size at birth, adult intestinal calcium absorption and 1,25 (OH)2 vitamin D. QJM. 95, 15–21 (2002).
Mitamura, R., Hara, H. & Aoyama, Y. Ingestion of raffinose promotes calcium absorption in the large intestine of rats. Biosci. Biotechnol. Biochem. 68, 384–389 (2004).
Bonjour, J. P., Fleisch, H. & Trechsel, U. Calcium absorption in diphosphonate-treated rats: effect of parathyroid function, dietary calcium and phosphorus. J. Physiol. 264, 125–139 (1977).
Jaeger, P., Jones, W., Clemens, T. L. & Hayslett, J. P. Evidence that calcitonin stimulates 1,25-dihydroxyvitamin D production and intestinal absorption of calcium in vivo. J. Clin. Invest. 78, 456–461 (1986).
Murayama, A. et al. Positive and negative regulations of the renal 25-hydroxyvitamin D3 1α-hydroxylase gene by parathyroid hormone, calcitonin, and 1α,25 (OH)2D3 in intact animals. Endocrinology 140, 2224–2231 (1999).
Zhang, Y. et al. Effects of Fructus Ligustri Lucidi extract on bone turnover and calcium balance in ovariectomized rats. Biol. Pharm. Bull. 29, 291–296 (2006).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Ku, SK., Cho, HR., Choi, JS. et al. Effects of Polycan on calcium bioavailability in two different rat models of osteoporosis. Toxicol. Environ. Health Sci. 7, 35–42 (2015). https://doi.org/10.1007/s13530-015-0218-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13530-015-0218-0